Predictors of Cardiovascular Events After Liver Transplantation

Juan F Gallegos-Orozco1, Michael R Charlton2

  • 1Division of Gastroenterology, Hepatology and Nutrition, University of Utah School of Medicine, 30 North 1900 East SOM 4R118, Salt Lake City, UT 84132, USA.

Insights

Liver transplant recipients, often older and sicker, face risks from cardiovascular disease. Pretransplant evaluation is crucial for identifying and mitigating these cardiac risks to improve patient outcomes.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Liver transplant indications have expanded, leading to increased transplantation in older, sicker patients.
  • Post-transplant mortality is significantly influenced by infectious, malignant, and cardiovascular diseases.
  • Cirrhosis can lead to various forms of heart disease, complicating patient management.

Purpose of the Study:

  • To highlight the increased cardiovascular risks in liver transplant candidates.
  • To emphasize the importance of pretransplant cardiovascular evaluation.
  • To identify key risk factors for post-transplant cardiovascular complications.

Main Methods:

  • Review of existing literature on liver transplantation and cardiovascular complications.
  • Analysis of risk factors associated with post-transplant mortality.
  • Identification of diagnostic tools for cardiovascular assessment in cirrhotic patients.

Main Results:

  • Cardiovascular disease is a leading cause of death after liver transplantation.
  • A history of cardiovascular disease and specific cardiac test abnormalities increase risk.
  • No single factor reliably predicts post-transplant cardiovascular complications.

Conclusions:

  • Pretransplant cardiovascular evaluation is essential for liver transplant candidates.
  • Identifying and managing pre-existing cardiac conditions can mitigate post-transplant risks.
  • Comprehensive cardiac assessment is vital for improving outcomes in liver transplant recipients.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...